FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127965499> ?p ?o ?g. }

• W3127965499 endingPage "898" @default.
• W3127965499 startingPage "890" @default.
• W3127965499 abstract "Background In this study, we investigated the risk factors of acquired T790M mutation among patients with lung adenocarcinoma with epidermal growth factor receptor (EGFR) tyrosine mutation who were treated with EGFR-tyrosine kinase inhibitors (TKIs). The aim was to identify the clinical impact of rebiopsy. Methods This multicenter, retrospective cohort study was conducted in South Korea from January 2007 to June 2017. Patients with adenocarcinoma with EGFR mutation who underwent rebiopsy and were treated with EGFR-TKIs were included. Results Of a total of 352 patients, T790M mutation was identified in 156 (41.9%) at the time of rebiopsy. The median duration from initial biopsy to rebiopsy was 17 months. Univariate logistic regression analysis revealed associations of exon 19 deletion (odds ratio [OR], 1.643; p = 0.026), absence of L858R (OR, 0.627; p = 0.042), and previous EGFR-TKI treatment duration (OR, 1.039; p < 0.001) with T790M mutation. Previous EGFR-TKI treatment duration (OR, 3.580; p < 0.001) was independently associated with T790M mutation. A multivariate Cox proportional hazard model revealed that brain metastasis at initial diagnosis (hazard ratio, 1.390; p = 0.050) tended to be associated with T790M mutation. Among the patients with T790M mutation at rebiopsy, the osimertinib user group (n = 90) had a better one-year survival (68.7 vs. 58.3%, p = 0.048) than the osimertinib nonuser group (n = 66). Conclusions Rebiopsy might affect the clinical course of patients with EGFR-mutant adenocarcinoma who receive EGFR-TKIs." @default.
• W3127965499 created "2021-02-15" @default.
• W3127965499 creator A5006227181 @default.
• W3127965499 creator A5019886336 @default.
• W3127965499 creator A5021370060 @default.
• W3127965499 creator A5024391055 @default.
• W3127965499 creator A5024831387 @default.
• W3127965499 creator A5036157714 @default.
• W3127965499 creator A5041035234 @default.
• W3127965499 creator A5063467902 @default.
• W3127965499 creator A5064663707 @default.
• W3127965499 creator A5066767378 @default.
• W3127965499 creator A5067788652 @default.
• W3127965499 creator A5070077415 @default.
• W3127965499 creator A5071110524 @default.
• W3127965499 creator A5071284791 @default.
• W3127965499 creator A5081114498 @default.
• W3127965499 creator A5082152803 @default.
• W3127965499 creator A5090182041 @default.
• W3127965499 date "2021-02-02" @default.
• W3127965499 modified "2023-10-18" @default.
• W3127965499 title "Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting" @default.
• W3127965499 cites W1979671400 @default.
• W3127965499 cites W1980497534 @default.
• W3127965499 cites W1990013637 @default.
• W3127965499 cites W1998971866 @default.
• W3127965499 cites W2066671159 @default.
• W3127965499 cites W2076178766 @default.
• W3127965499 cites W2098395191 @default.
• W3127965499 cites W2138089710 @default.
• W3127965499 cites W2145980885 @default.
• W3127965499 cites W2152024278 @default.
• W3127965499 cites W2154149901 @default.
• W3127965499 cites W2166084034 @default.
• W3127965499 cites W2548145417 @default.
• W3127965499 cites W2560717039 @default.
• W3127965499 cites W2566863750 @default.
• W3127965499 cites W2748695779 @default.
• W3127965499 cites W2792821195 @default.
• W3127965499 cites W2800477471 @default.
• W3127965499 cites W2802449201 @default.
• W3127965499 cites W2810969055 @default.
• W3127965499 cites W2900712986 @default.
• W3127965499 cites W2903834821 @default.
• W3127965499 cites W2914392425 @default.
• W3127965499 cites W2944874515 @default.
• W3127965499 cites W2979930936 @default.
• W3127965499 cites W2988908957 @default.
• W3127965499 cites W2989313910 @default.
• W3127965499 cites W3011476556 @default.
• W3127965499 doi "https://doi.org/10.1111/1759-7714.13857" @default.
• W3127965499 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7952806" @default.
• W3127965499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33529490" @default.
• W3127965499 hasPublicationYear "2021" @default.
• W3127965499 type Work @default.
• W3127965499 sameAs 3127965499 @default.
• W3127965499 citedByCount "2" @default.
• W3127965499 countsByYear W31279654992021 @default.
• W3127965499 countsByYear W31279654992022 @default.
• W3127965499 crossrefType "journal-article" @default.
• W3127965499 hasAuthorship W3127965499A5006227181 @default.
• W3127965499 hasAuthorship W3127965499A5019886336 @default.
• W3127965499 hasAuthorship W3127965499A5021370060 @default.
• W3127965499 hasAuthorship W3127965499A5024391055 @default.
• W3127965499 hasAuthorship W3127965499A5024831387 @default.
• W3127965499 hasAuthorship W3127965499A5036157714 @default.
• W3127965499 hasAuthorship W3127965499A5041035234 @default.
• W3127965499 hasAuthorship W3127965499A5063467902 @default.
• W3127965499 hasAuthorship W3127965499A5064663707 @default.
• W3127965499 hasAuthorship W3127965499A5066767378 @default.
• W3127965499 hasAuthorship W3127965499A5067788652 @default.
• W3127965499 hasAuthorship W3127965499A5070077415 @default.
• W3127965499 hasAuthorship W3127965499A5071110524 @default.
• W3127965499 hasAuthorship W3127965499A5071284791 @default.
• W3127965499 hasAuthorship W3127965499A5081114498 @default.
• W3127965499 hasAuthorship W3127965499A5082152803 @default.
• W3127965499 hasAuthorship W3127965499A5090182041 @default.
• W3127965499 hasBestOaLocation W31279654991 @default.
• W3127965499 hasConcept C121608353 @default.
• W3127965499 hasConcept C126322002 @default.
• W3127965499 hasConcept C143998085 @default.
• W3127965499 hasConcept C144301174 @default.
• W3127965499 hasConcept C156957248 @default.
• W3127965499 hasConcept C167135981 @default.
• W3127965499 hasConcept C207103383 @default.
• W3127965499 hasConcept C2776256026 @default.
• W3127965499 hasConcept C2777626846 @default.
• W3127965499 hasConcept C2777930144 @default.
• W3127965499 hasConcept C2778087573 @default.
• W3127965499 hasConcept C2779438470 @default.
• W3127965499 hasConcept C2780580887 @default.
• W3127965499 hasConcept C2781182431 @default.
• W3127965499 hasConcept C38180746 @default.
• W3127965499 hasConcept C44249647 @default.
• W3127965499 hasConcept C71924100 @default.
• W3127965499 hasConceptScore W3127965499C121608353 @default.
• W3127965499 hasConceptScore W3127965499C126322002 @default.
• W3127965499 hasConceptScore W3127965499C143998085 @default.

• next